ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,824Medicare Part D Prescriptions Filled, Including Refills

Rank: 177 out of 617

$370K Total Retail Price of All Prescriptions

Rank: 174 out of 617

379 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 379 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 379 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 6,305 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 475 374 1 1
SIMVASTATIN 328 310 2 2
HYDROCODONE-ACETAMINOPHEN 274 136 S3 3 8
OMEPRAZOLE 226 177 4 3
LISINOPRIL 214 191 5 5
FUROSEMIDE 211 188 6 4
WARFARIN SODIUM 188 183 7 7
METFORMIN HCL 182 168 8 9
GLIMEPIRIDE 156 144 9 33
AMLODIPINE BESYLATE 146 119 10 6
POTASSIUM CHLORIDE 143 127 11 10
HYDROCHLOROTHIAZIDE 143 113 11 13
METOPROLOL SUCCINATE 140 134 13 12
ATENOLOL 132 106 14 17
DONEPEZIL HCL 126 126 15 30
CARVEDILOL 119 109 16 19
ZOLPIDEM TARTRATE 100 62 17 23
ALENDRONATE SODIUM 99 91 18 25
CITALOPRAM HBR 97 93 19 18
TRAMADOL HCL 89 72 20 15
SERTRALINE HCL 89 85 20 20
PREDNISONE 78 74 22 31
PRAVASTATIN SODIUM 77 77 23 21
GABAPENTIN 77 40 23 16
ATORVASTATIN CALCIUM 71 70 25 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 69 26 29
TAMSULOSIN HCL 68 46 27 26
CELEBREX 65 65 28 63
RANITIDINE HCL 62 59 29 40
MELOXICAM 61 48 30 24
PROAIR HFA 61 30 30 75
METOPROLOL TARTRATE 61 56 30 11
PANTOPRAZOLE SODIUM 58 50 33 37
CYCLOBENZAPRINE HCL 56 0 R 34 74
AMOXICILLIN 56 38 34 135
SPIRIVA 51 44 36 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.